Fig. 2From: Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trialEffects of oxytocin nasal spray administration on social responsiveness. Visualization of changes from baseline in caregiver-reported social responsiveness (SRS-2 total raw scores) of the double-blind phase (phase I) and the single-blind phase (phase II), separately for each original nasal spray group (oxytocin-first, placebo-first) and assessment session (immediate post (T1 and T3)and four-week follow-up (T2 and T4)). Lower scores indicate improvement. Vertical bars denote ± standard errorsBack to article page